Identification of novel alternatively spliced isoforms of RTEF-1 within human ocular vascular endothelial cells and murine retina

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 8, 2007, Pages 3775-3782

  Appukuttan, Binoy ^a   McFarland, Trevor J ^a   Davies, Michael H ^a   Atchaneeyasakul, La Ongsri ^a   Zhang, Yi ^a   Babra, Bobby ^a   Pan, Yuzhen ^a   Rosenbaum, James T ^a   Acott, Ted ^a   Powers, Michael R ^a   Stout, J Timothy ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MESSENGER RNA; TRANSCRIPTIONAL ENHANCER FACTOR 1 RELATED PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; DNA BINDING PROTEIN; MUSCLE PROTEIN; TEAD4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN A;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; EXON; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMID; POSTNATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINOPATHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; ANIMAL; ANOXIA; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; ENDOTHELIUM CELL; ENHANCER REGION; GENETICS; HYPEROXIA; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROLENTAL FIBROPLASIA; UPREGULATION;

ALTERNATIVE SPLICING; ANIMALS; ANOXIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; ENHANCER ELEMENTS (GENETICS); HUMANS; HYPEROXIA; INFANT, NEWBORN; MICE; MICE, INBRED C57BL; MUSCLE PROTEINS; PROMOTER REGIONS (GENETICS); RETINAL VESSELS; RETINOPATHY OF PREMATURITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34648825513     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1172     Document Type: Article

References (29)

1. Kaneko KJ, DePamphilis ML. Regulation of gene expression at the beginning of mammalian development and the TEAD family of transcription factors. Dev Genet. 1998;22:43-55.
2. Stewart AF, Richard CW 3rd, Suzow J, et al. Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multi-gene family. Genomics. 1996;37:68-76.
3. Yasunami M, Suzuki K, Ohkubo H. A novel family of TEA domain-containing transcription factors with distinct spatiotemporal expression patterns. Biochem Biophys Res Commun. 1996;228:365-370.
4. Farrance IK, Ordahl CP. The role of transcription enhancer factor-1 (TEF-1) related proteins in the formation of M-CAT binding complexes in muscle and non-muscle tissues. J Biol Chem. 1996;271:8266-8274.
5. Zuzarte PC, Farrance IK, Simpson PC, et al. Tumor cell splice variants of the transcription factor TEF-1 induced by SV40 T-antigen transformation. Biochim Biophys Acta. 2000;1517:82-90.
6. Jiang SW, Trujillo MA, Sakagashira M, et al. Novel human TEF-1 isoforms exhibit altered DNA binding and functional properties. Biochemistry. 2000;39:3505-3513.
7. Frigerio JM, Berthezene P, Garrido P, et al. Analysis of 2166 clones from a human colorectal cancer cDNA library by partial sequencing. Hum Mol Genet. 1995;4:37-43.
8. Yockey CE, Smith G, Izumo S, et al. cDNA cloning and characterization of murine transcriptional enhancer factor-1-related protein 1, a transcription factor that binds to the M-CAT motif. J Biol Chem. 1996;271:3727-3736.
9. Shie JL, Wu G, Wu J, et al. RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J Biol Chem. 2004;279:25010-25016.
10. Kanda K, Hayman GT, Silverman MD, et al. Comparison of ICAM-1 and VCAM-1 expression in various human endothelial cell types and smooth muscle cells. Endothelium. 1998;6:33-44.
11. Silverman MD, Babra B, Pan Y, et al. Differential E-selectin expression by iris versus retina microvascular endothelial cells cultured from the same individuals. Microvasc Res. 2005;70:32-42.
12. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101-111.
13. Davies MH, Eubanks JP, Powers MR. Increased retinal neovascularization in Fas ligand-deficient mice. Invest Ophthalmol Vis Sci. 2003;44:3202-3210.
14. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604-4613.
15. Lashkari K, Hirose T, Yazdany J, et al. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol. 2000;156:1337-1344.
16. Miller JW. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol. 1997;151:13-23.
17. Vannay A, Dunai G, Banyasz I, et al. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res. 2005;57:396-398.
18. Young TL, Anthony DC, Pierce E, et al. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS. 1997;1:105-110.
19. Stewart AF, Suzow J, Kubota T, et al. Transcription factor RTEF-1 mediates α1-adrenergic reactivation of the fetal gene program in cardiac myocytes. Circ Res. 1998;83:43-49.
20. Ueyama T, Zhu C, Valenzuela YM, et al. Identification of the functional domain in the transcription factor RTEF-1 that mediates alpha 1-adrenergic signaling in hypertrophied cardiac myocytes. J Biol Chem. 2000;275:17476-17480.
21. Jacquemin P, Hwang JJ, Martial JA, et al. A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain. J Biol Chem. 1996;271:21775-21785.
22. Finkenzeller G, Sparacio A, Technau A, et al. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene. 1997;15:669-676.
23. Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996;114:1219-1228.
24. Donahue ML, Phelps DL, Watkins RH, et al. Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy. Curr Eye Res. 1996;15:175-184.
25. Pe'er J, Shweiki D, Itin A, et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72:638-645.
26. Xiao JH, Davidson I, Matthes H, et al. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell. 1991;65:551-568.
27. Seipel K, Georgiev O, Schaffner W. Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J. 1992;11:4961-4968.
28. Theill LE, Castrillo JL, Wu D, et al. Dissection of functional domains of the pituitary-specific transcription factor GHF-1. Nature. 1989;342:945-948.
29. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268:14553-14556.